Posts With Tag NASDAQ ENTO

Showing 1 - 1 of 1 Post

Entero Therapeutics, Inc. 8-K Report: Key Insights & Financial Overview

•

8-K

•

2025-01-13

Last updated: about 1 year ago

Entero Therapeutics, Inc. 8-K Report: Key Insights & Financial Overview

Explore Entero Therapeutics' 8-K filing from January 7, 2025, detailing company info, financial metrics, and SEC compliance.

Entero Therapeutics biotechnology NASDAQ ENTO financial reporting SEC compliance